ALLERNAZE Drug Patent Profile
✉ Email this page to a colleague
When do Allernaze patents expire, and what generic alternatives are available?
Allernaze is a drug marketed by Lupin Atlantis and is included in one NDA.
The generic ingredient in ALLERNAZE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Allernaze
A generic version of ALLERNAZE was approved as triamcinolone acetonide by TARO on October 1st, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALLERNAZE?
- What are the global sales for ALLERNAZE?
- What is Average Wholesale Price for ALLERNAZE?
Summary for ALLERNAZE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Patent Applications: | 4,295 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in ALLERNAZE? | ALLERNAZE excipients list |
| DailyMed Link: | ALLERNAZE at DailyMed |
US Patents and Regulatory Information for ALLERNAZE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Atlantis | ALLERNAZE | triamcinolone acetonide | SPRAY, METERED;NASAL | 020120-001 | Feb 4, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
